Charting new
territory in Molecular
Glue Discovery
Leadership
Board of Directors
Markus Warmuth
Chief Executive Officer
Owen Wallace
Chief Scientific Officer
Sharon Townson
Chief Technology Officer
John Castle
Chief Data and Information Officer
Filip Janku
Chief Medical Officer
Phil Nickson
General Counsel
Magnus Walter
SVP, Drug Discovery
Jennifer Champoux
Chief People and Operations Officer
Andrew Funderburk
SVP, Head of IR and Strategic Finance
Andrew Schiff (Chair)
Managing Partner, Aisling Capital
Alexander Mayweg
President, Ridgeline Discovery & Managing Director, Versant Ventures
Ali Behbahani
General Partner, New Enterprise Associates
Kimberly Blackwell
Chief Executive Officer, Zentalis Pharmaceuticals
Chandra P. Leo
Investment Advisor, HBM Partners
Christine Siu
Chief Operating Officer in Residence, BridgeBio
Markus Warmuth
Chief Executive Officer, Monte Rosa Therapeutics & Venture Partner, Versant Ventures
Jan Skvarka
Executive Chairman, DEM Biopharma
Tony Manning
Principal at Manning Bio Worldwide LLC
Are you ready to take
your career to new heights?
Are you ready to take
your career to new heights?
We are looking for enthusiastic and energetic candidates ready for their next adventure. Sound like you? Clip in, and help us scale new heights.